Analysis of the Gut Mycobiome in Adult Patients with Type 1 and Type 2 Diabetes Using Next-Generation Sequencing (NGS) with Increased Sensitivity—Pilot Study

• Main Authors: Dominika Salamon, Agnieszka Sroka-Oleksiak, Artur Gurgul, Zbigniew Arent, Magdalena Szopa, Małgorzata Bulanda, Maciej T. Małecki, Tomasz Gosiewski
• Format: Article
• Language: English
• Published: MDPI AG 2021-03-01
• Series: Nutrients
• Subjects: diabetes; gut mycobiome; next-generation sequencing (NGS)
• Online Access: https://www.mdpi.com/2072-6643/13/4/1066

The studies on microbiome in the human digestive tract indicate that fungi could also be one of the external factors affecting development of diabetes. The aim of this study was to evaluate the quantitative and qualitative mycobiome composition in the colon of the adults with type 1 (T1D), <i>n</i> = 26 and type 2 (T2D) diabetes, <i>n</i> = 24 compared to the control group, <i>n</i> = 26. The gut mycobiome was characterized in the stool samples using the analysis of the whole internal transcribed spacer (ITS) region of the fungal rDNA gene cluster by next-generation sequencing (NGS) with increased sensitivity. At the L2 (phylum) level, Basidiomycota fungi were predominant in all 3 study groups. Group T1D presented significantly lower number of Ascomycota compared to the T2D group, and at the L6 (genus) level, the T1D group presented significantly lower number of <i>Saccharomyces</i> genus compared to control and T2D groups. In the T1D group, a significant positive correlation between total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and fungi of the genus <i>Saccharomyces,</i> and in the T2D group, a negative correlation between the total cholesterol level and <i>Malassezia</i> genus was found. The obtained results seem to be a good foundation to extend the analysis of the relationship between individual genera and species of fungi and the parameters determining the metabolism of carbohydrates and lipids in the human body.